Small Company, Big Drug

genomeweb
360dx

Small Company, Big Drug

Feb 08, 2007

Will biotech “castoffs” develop the next blockbuster drugs?, asks a recent Wall Street Journal article ($).

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Illumina Launches $650M Senior Notes Offering
Bionano Genomics Reduces Size of Proposed IPO
Natera Partners With Fox Chase to Evaluate ctDNA Cancer Assay
Chinese FDA Approves Novogene CDx Test for NSCLC Therapies
UPDATE: GeneNews Posts 88 Percent Decline in Q2 Revenues; Inks Liquid Biopsy Alliance With LifeX
Biocept Q2 Revenues Fall 37 Percent

The Scan

Testing Less Likely

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three for Immunotherapy

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

This Week in Genome Research

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Cancer-Fighting Zombies

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.

Main menu